Literature DB >> 21305313

Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell's palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy.

Maria Riga1, G Kefalidis, A Chatzimoschou, G Tripsianis, S Kartali, H Gouveris, M Katotomichelakis, V Danielides.   

Abstract

Facial nerve oedema and anatomical predisposition to compression within the fallopian tube seem to be the only generally accepted facts in the pathophysiology of Bell's palsy. Several infectious causes have been suggested as possible triggers of this oedema. Most of the suggested pathogens have been associated with facial nerve lesions during latent infections, reinfections or endogenous reactivations. The aim of this study was to investigate the seroprevalence of three such pathogens Toxoplasma gondii, Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in a population of patients with facial nerve palsy. Fifty-six patients with Bell's palsy were included in the study. A group of 25 individuals with similar age and gender distribution was used as control. Seropositivity for T. gondii, EBV viral capsid antigen (VCA) and CMV-specific IgM and IgG antibodies was investigated 2-5 days after the onset of the palsy. Comparisons for both IgM and IgG antibodies against T. gondii attributed significantly higher seroprevalence in the patients' group than in the control group (p = 0.024 and 0.013, respectively). The respective examinations for EBV and CMV attributed no significant results. The roles of EBV and CMV in the pathogenesis of Bell's palsy were not confirmed by this study. However, a significantly higher seroprevalence of IgM- and IgG-specific T. gondii antibodies was detected in patients with Bell's palsy when compared to healthy controls. The possibility that facial nerve palsy might be a late complication of acquired toxoplasmosis may need to be addressed in further studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21305313     DOI: 10.1007/s00405-011-1499-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  45 in total

1.  Molecular mimicry in infectious encephalitis and neuritis: binding of antibodies against infectious agents on Western blots of human nervous tissue.

Authors:  P Birner; B Gatterbauer; D Drobna; H Bernheimer
Journal:  J Infect       Date:  2000-07       Impact factor: 6.072

2.  Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination.

Authors:  Henrik Lambert; Niclas Hitziger; Isabel Dellacasa; Mattias Svensson; Antonio Barragan
Journal:  Cell Microbiol       Date:  2006-10       Impact factor: 3.715

Review 3.  Immunity and Toxoplasma retinochoroiditis.

Authors:  G R Wallace; M R Stanford
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

4.  Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden.

Authors:  B Evengård; K Petersson; M L Engman; S Wiklund; S A Ivarsson; K Teär-Fahnehjelm; M Forsgren; R Gilbert; G Malm
Journal:  Epidemiol Infect       Date:  2001-08       Impact factor: 2.451

Review 5.  Mechanisms of innate resistance to Toxoplasma gondii infection.

Authors:  J Alexander; T M Scharton-Kersten; G Yap; C W Roberts; F Y Liew; A Sher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

6.  CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 8.  Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity.

Authors:  Maija Lappalainen; Klaus Hedman
Journal:  Ann Ist Super Sanita       Date:  2004       Impact factor: 1.663

9.  Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Mats Engström; Thomas Berg; Anna Stjernquist-Desatnik; Sara Axelsson; Anne Pitkäranta; Malou Hultcrantz; Mervi Kanerva; Per Hanner; Lars Jonsson
Journal:  Lancet Neurol       Date:  2008-10-10       Impact factor: 44.182

10.  Sensorineural hearing loss due to Toxoplasma gondii in children: a case-control study.

Authors:  S Noorbakhsh; F Memari; M Farhadi; A Tabatabaei
Journal:  Clin Otolaryngol       Date:  2008-06       Impact factor: 2.597

View more
  1 in total

1.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.